BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 25274307)

  • 1. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.
    Muppidi JR; Schmitz R; Green JA; Xiao W; Larsen AB; Braun SE; An J; Xu Y; Rosenwald A; Ott G; Gascoyne RD; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Vaidehi N; Staudt LM; Cyster JG
    Nature; 2014 Dec; 516(7530):254-8. PubMed ID: 25274307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G protein-coupled receptor P2RY8 and follicular dendritic cells promote germinal center confinement of B cells, whereas S1PR3 can contribute to their dissemination.
    Muppidi JR; Lu E; Cyster JG
    J Exp Med; 2015 Dec; 212(13):2213-22. PubMed ID: 26573295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling.
    Flori M; Schmid CA; Sumrall ET; Tzankov A; Law CW; Robinson MD; Müller A
    Blood; 2016 Mar; 127(11):1438-48. PubMed ID: 26729899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
    O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
    Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8.
    Lu E; Wolfreys FD; Muppidi JR; Xu Y; Cyster JG
    Nature; 2019 Mar; 567(7747):244-248. PubMed ID: 30842656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner.
    Xia Z; Zhang X; Liu P; Zhang R; Huang Z; Li D; Xiao X; Wu M; Ning N; Zhang Q; Zhang J; Liu M; Jiao B; Ren R
    Cell Death Dis; 2021 Jan; 12(1):54. PubMed ID: 33423045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
    Bedekovics T; Hussain S; Feldman AL; Galardy PJ
    Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S1PR2 links germinal center confinement and growth regulation.
    Green JA; Cyster JG
    Immunol Rev; 2012 May; 247(1):36-51. PubMed ID: 22500830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma.
    Stelling A; Hashwah H; Bertram K; Manz MG; Tzankov A; Müller A
    Blood; 2018 May; 131(20):2235-2246. PubMed ID: 29615404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphoma.
    Vockerodt M; Vrzalikova K; Ibrahim M; Nagy E; Margielewska S; Hollows R; Lupino L; Tooze R; Care M; Simmons W; Schrader A; Perry T; Abdullah M; Foster S; Reynolds G; Dowell A; Rudzki Z; Krappmann D; Kube D; Woodman C; Wei W; Taylor G; Murray PG
    J Pathol; 2019 Jun; 248(2):142-154. PubMed ID: 30666658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma.
    Stelling A; Wu CT; Bertram K; Hashwah H; Theocharides APA; Manz MG; Tzankov A; Müller A
    Blood Adv; 2019 Oct; 3(20):3020-3032. PubMed ID: 31648327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sphingosine 1-phosphate receptor S1P₂ maintains the homeostasis of germinal center B cells and promotes niche confinement.
    Green JA; Suzuki K; Cho B; Willison LD; Palmer D; Allen CD; Schmidt TH; Xu Y; Proia RL; Coughlin SR; Cyster JG
    Nat Immunol; 2011 Jun; 12(7):672-80. PubMed ID: 21642988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S1PR2 deficiency in DLBCL: a FOXy connection.
    Baldari CT
    Blood; 2016 Mar; 127(11):1380-1. PubMed ID: 26989186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired somatic mutations in non-coding region of bcl-6 gene in germinal center-type diffuse large B-cell lymphoma].
    Zhao J; Zhao J; Cai YY; Mao J; Yang KY; Chen GR; Zhou R
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):595-9. PubMed ID: 21092586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth.
    Bujisic B; De Gassart A; Tallant R; Demaria O; Zaffalon L; Chelbi S; Gilliet M; Bertoni F; Martinon F
    Blood; 2017 Apr; 129(17):2420-2428. PubMed ID: 28167662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
    Chen Y; Chen H; Fu K; Zhu XZ; Irons R
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.
    van der Meeren LE; Kluiver J; Rutgers B; Alsagoor Y; Kluin PM; van den Berg A; Visser L
    PLoS One; 2019; 14(10):e0223260. PubMed ID: 31603917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma.
    Dobashi A
    J Clin Exp Hematop; 2016; 56(2):71-78. PubMed ID: 27980305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.